| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 1761 |
| 1 | METHOTREXATE | 1544 |
| 2 | ETANERCEPT | 1297 |
| 3 | ADALIMUMAB | 1250 |
| 4 | LEFLUNOMIDE | 1122 |
| 5 | TOCILIZUMAB | 994 |
| 6 | ABATACEPT | 973 |
| 7 | PREDNISONE | 925 |
| 8 | TOFACITINIB | 883 |
| 9 | RITUXIMAB | 834 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLIMUMAB | 505 | 0.0401 |
| 1 | GOLD | 226 | 0.0389 |
| 2 | METHYLPREDNISOLONE ACETATE | 139 | 0.0171 |
| 3 | DIMENHYDRINATE | 157 | 0.0146 |
| 4 | PRAMIPEXOLE DIHYDROCHLORIDE | 69 | 0.0142 |
| 5 | FEBUXOSTAT TABLETS 40 MG | 143 | 0.0137 |
| 6 | LEFLUNOMIDE | 1122 | 0.0107 |
| 7 | SULFASALAZINE | 761 | 0.0103 |
| 8 | FEBUXOSTAT | 164 | 0.0096 |
| 9 | AZATHIOPRINE SODIUM | 24 | 0.0095 |
| # | Drug class | Count |
|---|---|---|
| 0 | Folate Analog Metabolic Inhibitor [EPC] | 1554 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 1468 |
| 2 | Antirheumatic Agent [EPC] | 1124 |
| 3 | Corticosteroid [EPC] | 1124 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 1011 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 973 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 894 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 840 |
| 8 | Aminosalicylate [EPC] | 761 |
| 9 | Vitamin B12 [EPC] | 578 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antirheumatic Agent [EPC] | 1124 | 0.0106 |
| 1 | Aminosalicylate [EPC] | 761 | 0.0076 |
| 2 | Provitamin D2 Compound [EPC] | 223 | 0.0075 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 1011 | 0.0073 |
| 4 | Selective T Cell Costimulation Modulator [EPC] | 973 | 0.0070 |
| 5 | Alkaloid [EPC] | 163 | 0.0061 |
| 6 | Interleukin-17A Antagonist [EPC] | 180 | 0.0048 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 1554 | 0.0035 |
| 8 | Purine Antimetabolite [EPC] | 303 | 0.0031 |
| 9 | Parenteral Iron Replacement [EPC] | 40 | 0.0029 |